Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 170 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
COPD Patients with Non-Small Cell Lung Cancer Respond Better to Anti-Pd-(l)1 Immune Checkpoint Inhibitors
Augustin Boudoussier, Iban Larrouture, Pauline Henrot,Rémi Veillon, Claire Bardel, Camille Chautemps, Charline Caumont,Pierre Schilfarth,Michael Duruisseaux, Maeva Zysman
Scientific reportsno. 1 (2025): 17145-17145
Cited0Views0WOSBibtex
0
0
Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study
Jean Mourlanette, Gaelle Rousseau-Bussac, Siham Mallah,Florian Guisier, Gerard Zalcman,Rémi Veillon,Clarisse Audigier-Valette,Magali Roa, Isabelle Nicolle, Helene Doubre, Nicolas Cloarec, Régine Lamy,Hugues Morel, Hubert Curcio, Aurélie Lagrange,Roland Schott, Marielle Sabatini, Anne Claire Toffart, Julian Pinsolle,Jaafar Bennouna,Christos Chouaid,Julien Mazieres
Targeted Oncologyno. 2 (2025): 311-317
Cited0Views0WOSBibtex
0
0
First-Line Pembrolizumab Efficacy in Octogenarians with NSCLCs Expressing ≥ 50% PD-L1 (ESCKEYP GFPC 05-2018)
Romain Corre,Chantal Decroisette, Jean-Bernard Auliac, Lionel Falchero, Hubert Curcio, Karim Amrane,Maurice Perol,Stéphane Hominal, Sabine Vieillot,Eric Huchot, Anne Laure Desage, Marie Bernardi,Remi Veillon, Hélène Doubre, Suzanna Bota, Gwenaelle Legarff,Grégoire Justeau, Oliver Bylicki,Magali Roa, Renaud Descourt,Christos Chouaïd, Laurent Greillier
Clinical lung cancer（2025）
Cited0Views0WOSBibtex
0
0
Load More
Author Statistics

#Papers: 170

#Citation: 7562

H-Index: 23

G-Index: 85

Sociability: 7

Diversity: 3

Activity: 59

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn